Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellino Biotech
Cambridge, Massachusetts, United States
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Cellino’s Nebula platform automates generation of patient-specific iPSC-derived cells/tissues for regenerative therapies using AI-driven, laser-based optical bioprocesses; selected by ARPA-H for $25M NEBULA project and received FDA AMT designation. The company’s first application is manufacturing retinal pigment epithelium for vision restoration, with plans to expand to larger organs such as heart and nervous system tissues. The Karis Bio partnership is moving toward clinical trials for cardiovascular indications
- Therapeutic areas
- NephrologyCardiovascularOphthalmologyEndocrinologyNeurologyMetabolic Disorders
- Modalities
- Induced pluripotent stem cell derived therapyCell therapyAutologous cell therapyPlatform for cell/tissue manufacturing
- Industry
- Biotech
02
Partnerships
Karis Bio (autologous iPSC therapy for cardiovascular disease)Mass General Brigham (Gene and Cell Therapy Institute; hospital-based iPSC manufacturing partnership)
Beyond the preview
Go deeper on Cellino Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellino Biotech.